WallStSmart
RGEN

Repligen Corporation

NASDAQ: RGEN · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES

$113.11
-3.68% today

Updated 2026-04-29

Market cap
$6.38B
P/E ratio
131.52
P/S ratio
8.64x
EPS (TTM)
$0.86
Dividend yield
52W range
$110 – $176
Volume
0.9M

Repligen Corporation (RGEN) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item20052006200720082009201020112012201320142015201620172018201920202021202220232024
Total assets$28.60M$29.08M$68.84M$73.75M$71.42M$72.29M$76.10M$97.01M$118.64M$-65.43M$146.24M$288.91M$120.41M$139.45M$1.40B$1.90B$2.36B$2.53B$2.82B$2.83B
Cash & equivalents
Current assets$21.51M$25.73M$54.42M$54.78M$59.68M$55.84M$46.90M$66.21M$86.35M$80.95M$103.25M$184.15M$242.78M$275.74M$641.83M$902.38M$931.68M$998.12M$1.11B$1.07B
Total liabilities$3.54M$4.73M$4.63M$5.30M$5.21M$5.21M$10.10M$12.89M$14.76M$16.56M$23.49M$120.15M$151.92M$159.05M$340.35M$373.74M$608.29M$620.90M$853.21M$856.95M
Current liabilities$2.94M$3.34M$4.59M$4.55M$4.66M$4.62M$7.50M$10.75M$11.30M$10.68M$18.78M$21.07M$25.21M$129.84M$48.31M$318.96M$375.26M$404.20M$158.16M$126.79M
Long-term debt$114000.00$76000.00$42000.00$0.00$0.00$0.00$0.00$0.00$95.27M$99.25M$232.77M$510.14M$525.57M
Shareholder equity
Retained earnings$-156.79M$-157.68M$-120.58M$-113.86M$-117.92M$-117.96M$-119.30M$-105.15M$-89.06M$-80.89M$-71.54M$-59.86M$-31.51M$-15.57M$5.84M$65.77M$194.06M$397.27M$438.85M$407.35M
Accounts receivable$1.31M$1.55M$2.58M$2.87M$3.88M$3.77M$6.10M$13.43M$11.89M$8.00M$11.45M$16.06M$27.74M$35.75M$43.67M$71.39M$117.42M$116.25M$124.16M$134.12M
Inventory$1.47M$1.51M$2.80M$2.41M$2.20M$1.95M$13.40M$11.14M$11.80M$12.38M$18.00M$24.70M$39.00M$42.26M$54.83M$95.03M$184.49M$238.28M$202.32M$142.96M
Goodwill$994.00M$994000.00$994000.00$1.00M$994000.00$994000.00$14.18M$14.35M$59.55M$327.33M$326.74M$468.41M$618.30M$860.36M$855.51M$987.12M$1.03B